Brief: Drugs Made In America Acquisition Merger Agreement Provides For Closing Valuation Of $2.85 Billion Including Apqc Acquisition - SEC FilingWed 23:05
Brief: Drugs Made In America Acquisition Corp - Enters Loi For De-Spac With Power Analytics Global Corp - SEC Filing08/04/2026 14:09